Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Obrecht

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1985
Chemotactic anti-tumor antibodies: in vitro results with four different antibody preparationsR Obrist, J P Obrecht, R C Bast, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Acute and subacute toxicity of chemotactic conjugates between monoclonal antibody and fMet-Leu-Phe in humans: a phase I clinical trialR Obrist, J Schmidli, R Müller, et al.
Schweizerische Medizinische Wochenschrift|July 10, 1976
[Simultaneous combination of adriamycin, bleomycin, cyclohexyl-chloroethyl nitrosourea with dimethyl-triazeno imidazole carboxamide in the treatment of Hodgkin's lymphoma]R Abele, P Alberto, G Germano, et al.
Strahlentherapie|December 1, 1977
[Diagnostic laparotomy in Hodgkin's disease: indication, management, results (author's transl)]R Sauer, R Hünig, F Harder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Single high-dose recombinant human granulocyte-macrophage colony stimulating factor: results of a phase I tolerability studyA Dieterle, A Gratwohl, R Ritz, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1987
Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopheroleC U Ludwig, H R Stoll, R Obrist, et al.
Schweizerische Medizinische Wochenschrift|September 8, 1973
[Side-effects of cytostatic agents]A C Mayr, G A Nagel, H J Dick, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
Vindesine. A clinical trial with special reference to neurological side effectsR Obrist, U Paravicini, D Hartmann, et al.
Invasion & Metastasis|January 1, 1989
Selection of highly malignant tumour cells using reconstituted basement membrane matrixK Tullberg, H Haidvogl, R Obrist, et al.
Blut|October 1, 1983
Functional characterization of T lymphocytes grown in semisolid agarC U Ludwig, H K Forster, M Troxler, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Advances in Experimental Medicine and Biology|January 1, 1985
Chemotactic anti-tumor antibodies: in vitro results with four different antibody preparationsR Obrist, J P Obrecht, R C Bast, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Acute and subacute toxicity of chemotactic conjugates between monoclonal antibody and fMet-Leu-Phe in humans: a phase I clinical trialR Obrist, J Schmidli, R Müller, et al.
Schweizerische Medizinische Wochenschrift|July 10, 1976
[Simultaneous combination of adriamycin, bleomycin, cyclohexyl-chloroethyl nitrosourea with dimethyl-triazeno imidazole carboxamide in the treatment of Hodgkin's lymphoma]R Abele, P Alberto, G Germano, et al.
Strahlentherapie|December 1, 1977
[Diagnostic laparotomy in Hodgkin's disease: indication, management, results (author's transl)]R Sauer, R Hünig, F Harder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Single high-dose recombinant human granulocyte-macrophage colony stimulating factor: results of a phase I tolerability studyA Dieterle, A Gratwohl, R Ritz, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1987
Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopheroleC U Ludwig, H R Stoll, R Obrist, et al.
Schweizerische Medizinische Wochenschrift|September 8, 1973
[Side-effects of cytostatic agents]A C Mayr, G A Nagel, H J Dick, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
Vindesine. A clinical trial with special reference to neurological side effectsR Obrist, U Paravicini, D Hartmann, et al.
Invasion & Metastasis|January 1, 1989
Selection of highly malignant tumour cells using reconstituted basement membrane matrixK Tullberg, H Haidvogl, R Obrist, et al.
Blut|October 1, 1983
Functional characterization of T lymphocytes grown in semisolid agarC U Ludwig, H K Forster, M Troxler, et al.
Pageof 13